MedPath

Perform blood test to know the value of fats, glucose and anthropometric measurements in people who do Intermittent Fasting

Phase 3
Conditions
Metabolic Syndrome, Obesity.
C18.452
Registration Number
RBR-6vbzs7m
Lead Sponsor
niversidade Professor Edson Antônio Vellano
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Patients with an overweight body mass index, grade 1 obesity, or grade 2 obesity.

Exclusion Criteria

Patients who did not follow the diet correctly.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate which diet provides greater weight loss with increased lean mass and decreased fat mass.
Secondary Outcome Measures
NameTimeMethod
It is expected to observe a significant decrease in the biochemical parameters of glycemia and lipid profile measured before and after the intervention.
© Copyright 2025. All Rights Reserved by MedPath